- Email: [email protected]
Volume 16 Contents, Keyword and Author Index
Volume 16, 2005 List of Contents, Keywords and Author Indexes
doi:10.1016/S1359-6101(05)00142-5
EDITOR Professor John Hiscott Director, Molecular Oncology Group Lady Davis Institute for Medical Research Jewish General Hospital 3755 Cote Ste. Catherine Montreal, CANADA H3T 1E2 Tel.: (514) 340-8222 Fax: (514) 340 7576 Email: [email protected] EDITORIAL BOARD C Basilico (USA) M V Chao (USA) S Durum (USA) M Feldmann (UK) M Fenton (USA) C-H Heldin (Sweden) D J Hilton (Australia) T Hirano (Japan) J Hiscott (Canada) J Keski-Oja (Finland) M Klagsbrun (USA) M Krönke (Germany) W Leonard (USA) D LeRoith (USA) D Levy (USA) K Miyazono (Japan) C F Nathan (USA)
J J Oppenheim (USA) R W Padgett (USA) S Pestka (USA) K Pfizenmaier (Germany) H A Reddi (USA) A B Roberts (USA) G Rodan (USA) J Schlessinger (USA) M D Schneider (USA) M B Sporn (UK) T Taniguchi (Japan) G Trinchieri (France) J Van Damme (Belgium) J T Vilcˇek (USA) S Wahl (USA) D Wallach (Israel) C Ware (USA)
Author enquiries: For enquiries relating to the submission of articles (including electronic submission where available) please visit Elsevier’s Author Gateway at http://authors.elsevier.com. The Author Gateway also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article’s status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication. Publication information: Cytokine and Growth Factor Reviews (ISSN 1359-6101). For 2006, volume 17 is scheduled for publication. Subscription prices are available upon request from the Publisher or from the Regional Sales Office nearest you or from this journal’s website (http://www.elsevier.com/locate/cytogfr). Further information is available on this journal and other Elsevier products through Elsevier’s website: (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch. Advertising information: Advertising orders and enquiries can be sent to: USA, Canada and South America: Mr Tino DeCarlo, The Advertising Department, Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710, USA; phone: (+1) (212) 633 3815; fax: (+1) (212) 633 3820; e-mail: [email protected]. Europe and ROW: Daniel Banks, Commercial Sales Department, Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 3BL, UK; phone: (+44) (0) 1865 843652; fax: (+44) (0) 1865 843976; e-mail: [email protected] Orders, claims, and journal enquiries: please contact the Customer Service Department at the Regional Sales Office nearest you: Orlando: Elsevier, Customer Service Department, 6277 Sea Harbor Drive, Orlando, FL 32887-4800, USA; phone: (+1) (877) 8397126 [toll free number for US customers], or (+1) (407) 3454020 [customers outside US]; fax: (+1) (407) 3631354; e-mail: [email protected] Amsterdam: Elsevier, Customer Service Department, PO Box 211, 1000 AE Amsterdam, The Netherlands; phone: (+31) (20) 4853757; fax: (+31) (20) 4853432; e-mail: [email protected] Tokyo: Elsevier, Customer Service Department, 4F Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; phone: (+81) (3) 5561 5037; fax: (+81) (3) 5561 5047; e-mail: [email protected] Singapore: Elsevier, Customer Service Department, 3 Killiney Road, #08-01 Winsland House I, Singapore 239519; phone: (+65) 63490222; fax: (+65) 67331510; e-mail: [email protected] USA mailing notice: Cytokine and Growth Factor Reviews (ISSN 1359-6101) is published bimonthly in February, April, June, August, October and December by Elsevier (P.O. Box 211, 1000 AE Amsterdam, The Netherlands). Annual subscription price in the USA US$ 704 (valid in North, Central and South America), including air speed delivery. Periodical postage rate is paid at Jamaica, NY 11431. USA POSTMASTER: Send address changes to Cytokine and Growth Factor Reviews, Publications Expediting Inc., 200 Meacham Ave, Elmont, NY 11003. AIRFREIGHT AND MAILING in the USA by Publications Expediting Inc., 200 Meacham Avenue, Elmont, NY 11003. © 2006 Elsevier Ltd. All rights reserved.
Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
CONTENTS Volume 16, Number 1 Surveys Transcriptional signaling by double-stranded RNA: role of TLR3 (G.C. Sen and S.N. Sarkar)
1
Dual role for TGF-1 in apoptosis (A. Sánchez-Capelo)
15
Tumor necrosis factor, cancer and anticancer therapy (S. Mocellin, C.R. Rossi, P. Pilati and D. Nitti)
35
Tumor therapeutics by design: targeting and activation of death receptors (H. Wajant, J. Gerspach and K. Pfizenmaier)
55
Transcriptional regulation of vascular endothelial growth factor in cancer (R.M.B. Loureiro and P.A. D’Amore)
77
Viral chemokine-modulatory proteins: tools and targets (J.M. Boomker, L.F.M.H. de Leij, T. Hauw The and M.C. Harmsen)
91
Facts and Faces Conference Calendar Information to Contributors
I V VII
Volume 16, Number 2 Special Issue: Fibroblast Growth Factors Editorial: Introduction to the special FGF issue (C. Basilico)
105
Structural basis for fibroblast growth factor receptor activation (M. Mohammadi, S.K. Olsen and O.A. Ibrahimi)
107
Cellular signaling by fibroblast growth factor receptors (V.P. Eswarakumar, I. Lax and J. Schlessinger)
139
FGF signaling in flies and worms: More and more relevant to vertebrate biology (P. Huang and M.J. Stern)
151
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis (M. Presta, P. Dell’Era, S. Mitola, E. Moroni, R. Ronca and M. Rusnati)
159
Fibroblast growth factor signaling in tumorigenesis (R. Grose and C. Dickson)
179
Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations (A.O.M. Wilkie)
187
FGF signaling in the developing endochondral skeleton (D.M. Ornitz)
205
Volume Contents/Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
IX
Fibroblast growth factor homologous factors: Evolution, structure, and function (M. Goldfarb)
215
FGF23 and disorders of phosphate homeostasis (X. Yu and K.E. White)
221
Mechanisms underlying differential responses to FGF signaling (L. Dailey, D. Ambrosetti, A. Mansukhani and C. Basilico)
233
Facts and Faces Conference Calendar Information to Contributors
I III V
Volume 16, Number 3 Special Issue: Bone Morphogenetic Proteins Editorial BMPs: From bone morphogenetic proteins to body morphogenetic proteins (A.H. Reddi)
249
Reviews BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk (K. Miyazono, S. Maeda and T. Imamura)
251
BMP signaling and early embryonic patterning (S. Kishigami and Y. Mishina)
265
The role of bone morphogenetic proteins in endochondral bone formation (N. Tsumaki and H. Yoshikawa)
279
Bone Morphogenetic Protein signaling in joint homeostasis and disease (R.J.U. Lories and F.P. Luyten)
287
Bone morphogenetic proteins in development and homeostasis of kidney (P. Simic and S. Vukicevic)
299
BMP antagonists: Their roles in development and involvement in pathophysiology (M. Yanagita)
309
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation (R.L. van Bezooijen, P. ten Dijke, S.E. Papapoulos and C.W.G.M. Löwik)
319
Delivery of bone morphogenetic proteins for orthopedic tissue regeneration (H. Seeherman and J.M. Wozney)
329
Application of bone morphogenetic proteins in spinal fusion (M.C. Gupta and S.N. Khan)
347
Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: Experimental studies in the non-human primate Papio ursinus (U. Ripamonti, N.-N. Herbst and L.N. Ramoshebi)
357
Bone morphogenetic proteins in dentin regeneration for potential use in endodontic therapy (M. Nakashima)
369
Facts and Faces Conference Calendar Information to Contributors
I V VII
X
Volume Contents/Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
Volume 16, Numbers 4–5 Mini-reviews Should activin C be more than a fading snapshot in the activin/TGF family album? (C.M. Butler, E.J. Gold and G.P. Risbridger)
377
MicroRNAs: Small regulators with a big impact (M. Yang, Y. Li and R.W. Padgett)
387
Surveys Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension (J.L. Walker, A.K. Fournier and R.K. Assoian)
395
The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models (S. Yakar, D. LeRoith and P. Brodt)
407
Molecular interactions of the IGF system (A. Denley, L.J. Cosgrove, G.W. Booker, J.C. Wallace and B.E. Forbes)
421
RET tyrosine kinase signaling in development and cancer (E. Arighi, M.G. Borrello and H. Sariola)
441
Cytokines and junction restructuring during spermatogenesis—a lesson to learn from the testis (W. Xia, D.D. Mruk, W.M. Lee and C.Y. Cheng)
469
Smads and chromatin modulation (L.A. van Grunsven, G. Verstappen, D. Huylebroeck and K. Verschueren)
495
Cell biology of IL-7, a key lymphotrophin (Q. Jiang, W.Q. Li, F.B. Aiello, R. Mazzucchelli, B. Asefa, A.R. Khaled and S.K. Durum)
513
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis (M. Klagsbrun and A. Eichmann)
535
Facts and Faces Conference Calendar Information to Contributors
I V VII
Volume 16, Number 6 Special Issue: Chemokines Editorial From cytokines to chemokines (J. Van Damme and A. Mantovani)
549
Reviews Chemokines provide the sustained inflammatory bridge between innate and acquired immunity (A.L. Coelho, C.M. Hogaboam and S.L. Kunkel)
553
Synergy in cytokine and chemokine networks amplifies the inflammatory response (M. Gouwy, S. Struyf, P. Proost and J. Van Damme)
561
Dendritic cell trafficking: More than just chemokines (S. Sozzani)
581
Volume Contents/Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
XI
CXC chemokines in angiogenesis (R.M. Strieter, M.D. Burdick, B.N. Gomperts, J.A. Belperio and M.P. Keane)
593
Dimerization of chemokine receptors and its functional consequences (J.-Y. Springael, E. Urizar and M. Parmentier)
611
Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention (Z. Johnson, A.E. Proudfoot and T.M. Handel)
625
Chemokine receptor internalization and intracellular trafficking (N.F. Neel, E. Schutyser, J. Sai, G.-H. Fan and A. Richmond)
637
HIV chemokine receptor inhibitors as novel anti-HIV drugs (K. Princen and D. Schols)
659
Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines (M. Locati, Y.M. de la Torre, E. Galliera, R. Bonecchi, H. Bodduluri, G. Vago, A. Vecchi and A. Mantovani)
679
Contribution of Duffy antigen to chemokine function (A. Rot)
687
Facts and Faces Conference Calendar Information to Contributors
I III IV
Cytokine & Growth Factor Reviews 17 (2006) XII–XIII
KEY WORD INDEX Achondroplasia 205 Activin C 377 Adaptive immunity 553 Adaptors 469 Adherens junction 469 Adhesion molecules 581 ADHR 221 Akt 15 Angiogenesis 77, 159, 535, 593 Angiostasis 593 Antagonist 659 Anti-angiogenesis 77 Antibody fusion protein 55 Antineoplastic agent 35 Antitumor therapy 35 Antiviral drugs 91 Apoptosis 15, 377, 513 Biopharmaceutics 91 Blood-testis barrier 469 BMP 251, 265 BMP-7 acute and chronic renal failure 299 Bone 187 Bone formation, BMP antagonist 319 Bone induction 357 Bone morphogenetic proteins (BMPs) 287, 329, 347, 357, 369, 495 C. elegans 151 Cadherin 395 Cancer 179, 407 Cartilage 279 CCR5 659 Cdk 513 Cell cycle 513 Cellular signaling 139 Chemokine receptor 637, 659, 679 Chemokine therapeutics 625 Chemokines 553, 561, 581, 593, 611, 625, 679, 687, 91 Chemotaxis 561 Composites 329 Cooperativity 611 Craniosynostosis 187, 205 CXCR4 659
Cyclin 395 Cystine-knot 309 Cytokines 469, 561 D6 679 DARC 687 Decoy receptors 679 Delivery systems 329 Dendritic cells 581 Dental pulp 369 Dental pulp capping 369 Development 387 Dimeric protein 377 Dimerization 139, 611 Double-stranded RNA 1 Drosophila 151 Ectodin 309 Ectoplasmic specialization 469 Embryogenesis 265 Embryonic patterning 265 Endocytosis 637 Endothelium 159, 687 Ephrin/Eph 535 ERK 469 Erythrocytes 687 FasL 15, 55 FGF 159, 205, 221, 233 FGF receptors 159, 179 FGF signaling 151 FGF23 221 FGFR 187, 233 FGFR stimulation 139 FGFs 179 Fibroproliferation 593 Fibrous dysplasia 221 Function 421 G1 phase 395 GAG 625 Gastrulation 265 GDNF 441 Gene regulation 387 Gene therapy 55, 329, 369 Gene transcription 233
Genetics 187 Glycosaminoglycan 625 GPCR 611 Growth factors 77, 377 Heparan sulfate proteoglycan 625 Heparin 625 Hirschsprung’s disease 441 Histones 495 HIV 659 IGF receptors 421 IGFBP 421 IL-7 513 Immune evasion 91 Immunosuppression 91 Induction 561 Inflammation 593, 679 Inhibin 377 Innate immunity 553 Inorganic carriers 329 Insulin-like growth factor 407, 421 Integrin 395 Interceptor 687 Internalization 637 JNK 15, 469 Junction restructuring 469 Kidney 299 Knockout mice 279 Leukocyte emigration 687 Mechanical force 395 Mesoderm 151 Metabolic bone disease 221 MicroRNA 387 Migration 151, 581 Modifications 637 Mouse models 407 Multiple endocrine neoplasia type 2 441 Natural polymers 329 Netrin/UNC5B 535
Keywords Index/Cytokine & Growth Factor Reviews 17 (2006) XII–XIII
Neuronal guidance 535 NF-B 15 Odontoblasts 369 Osteoarthritis 287 Osteocyte 319 Osteogenic protein-1 357 p38 15 p38 MAPK 469 Phosphate wasting 221 PI3 kinase 1 Primates 357 Receptor 265, 407 Receptor tyrosine kinase 205, 395 Receptor tyrosine phosphorylation 1 Receptors 581 Redundancy 357 Regeneration 369 Remodeling 495 Renal osteodystrophy 299 Reparative dentin 369 RET 441 rhBMP-2 347 rhBMP-7 347 Rheumatoid arthritis 287 rhGDF-5 347 RNA 387 ROS 15
Sclerosteosis/Van Buchem disease 319 Sclerostin 309 Semaphorin/neuropilin 535 Sepsis 553 Serine/threonine kinase receptor 251 Signal transduction 233, 495 Signaling cross-talk 251 Skeletal development 205 Slit/Robo 535 Smad 251, 495 Smads 279 Smurfs 279 SOST/sclerostin 319 Sperm 187 Spermatogenesis 469 Spinal fusion 347 Spondyloarthritis 287 Structure 421 Synergy 561 Synovial joint 287 Synthetic polymers 329 T cell 513 Testis 469 TGF- 251, 265 TGF- superfamily members 357 TGF-1 15 TGF-3 469
Thymus 513 Thyroid cancer 441 Tight junction 469 TIO 221 TNF 55 TNF 469 Toll-like receptor 3 1 Toll-like receptor (TLR) 553 Trafficking 637 TRAIL 55 Transcytosis 687 Transgenic mice 279 Tumor 159 Tumor necrosis factor (TNF) 35 Tumor targeting 55 Tumorgenesis 593 Tumors 535, 77 USAG-1 309 Vascular calcification 299 Vascularization 77 VEGF 77 Viral stress-inducible genes 1 Wise 309 Wnt signaling 233 XIAP 15 XLH 221
XIII
Cytokine & Growth Factor Reviews 17 (2006) XIV–XV
AUTHOR INDEX Aiello, F.B. 513 Ambrosetti, D. 233 Arighi, E. 441 Asefa, B. 513 Assoian, R.K. 395 Basilico, C. 105, 233 Belperio, J.A. 593 Bodduluri, H. 679 Bonecchi, R. 679 Booker, G.W. 421 Boomker, J.M. 91 Borrello, M.G. 441 Brodt, P. 407 Burdick, M.D. 593 Butler, C.M. 377 Cheng, C.Y. 469 Coelho, A.L. 553 Cosgrove, L.J. 421 Dailey, L. 233 Damme, J.V. 549 D’Amore, P.A. 77 de la Torre, Y.M. 679 de Leij, L.F.M.H. 91 Dell’Era, P. 159 Denley, A. 421 Dickson, C. 179 Durum, S.K. 513 Eichmann, A. 535 Eswarakumar, V.P. 139 Fan, G.-H. 637 Forbes, B.E. 421 Fournier, A.K. 395 Galliera, E. 679 Gerspach, J. 55 Gold, E.J. 377 Goldfarb, M. 215 Gomperts, B.N. 593 Gouwy, M. 561
Grose, R. 179 Gupta, M.C. 347 Handel, T.M. 625 Harmsen, M.C. 91 Herbst, N.-N. 357 Hogaboam, C.M. 553 Huang, P. 151 Huylebroeck, D. 495 Ibrahimi, O.A. 107 Imamura, T. 251 Jiang, Q. 513 Johnson, Z. 625 Keane, M.P. 593 Khaled, A.R. 513 Khan, S.N. 347 Kishigami, S. 265 Klagsbrun, M. 535 Kunkel, S.L. 553 Lax, I. 139 Lee, W.M. 469 LeRoith, D. 407 Li, W.Q. 513 Li, Y. 387 Locati, M. 679 Lories, R.J.U. 287 Loureiro, R.M.B. 77 Löwik, C.W.G.M. 319 Luyten, F.P. 287 Maeda, S. 251 Mansukhani, A. 233 Mantovani, A. 549, 679 Mazzucchelli, R. 513 Mishina, Y. 265 Mitola, S. 159 Miyazono, K. 251 Mocellin, S. 35 Mohammadi, M. 107 Moroni, E. 159
Mruk, D.D. 469 Nakashima, M. 369 Neel, N.F. 637 Nitti, D. 35 Olsen, S.K. 107 Ornitz, D.M. 205 Padgett, R.W. 387 Papapoulos, S.E. 319 Parmentier, M. 611 Pfizenmaier, K. 55 Pilati, P. 35 Presta, M. 159 Princen, K. 659 Proost, P. 561 Proudfoot, A.E. 625 Ramoshebi, L.N. 357 Reddi, A.H. 249 Richmond, A. 637 Ripamonti, U. 357 Risbridger, G.P. 377 Ronca, R. 159 Rossi, C.R. 35 Rot, A. 687 Rusnati, M. 159 Sai, J. 637 Sánchez-Capelo, A. 15 Sariola, H. 441 Sarkar, S.N. 1 Schlessinger, J. 139 Schols, D. 659 Schutyser, E. 637 Seeherman, H. 329 Sen, G.C. 1 Simic, P. 299 Sozzani, S. 581 Springael, J.-Y. 611 Stern, M.J. 151 Strieter, R.M. 593 Struyf, S. 561
Keywords Index/Cytokine & Growth Factor Reviews 17 (2006) XIV–XV
ten Dijke, P. 319 The, T.H. 91 Tsumaki, N. 279
Vecchi, A. 679 Verschueren, K. 495 Verstappen, G. 495 Vukicevic, S. 299
Wilkie, A.O.M. 187 Wozney, J.M. 329 Xia, W. 469
Urizar, E. 611 Vago, G. 679 van Bezooijen, R.L. 319 Van Damme, J. 561 van Grunsven, L.A. 495
Wajant, H. 55 Walker, J.L. 395 Wallace, J.C. 421 White, K.E. 221
Yakar, S. 407 Yanagita, M. 309 Yang, M. 387 Yoshikawa, H. 279 Yu, X. 221
XV
doi:10.1016/S1359-6101(05)00142-5
EDITOR Professor John Hiscott Director, Molecular Oncology Group Lady Davis Institute for Medical Research Jewish General Hospital 3755 Cote Ste. Catherine Montreal, CANADA H3T 1E2 Tel.: (514) 340-8222 Fax: (514) 340 7576 Email: [email protected] EDITORIAL BOARD C Basilico (USA) M V Chao (USA) S Durum (USA) M Feldmann (UK) M Fenton (USA) C-H Heldin (Sweden) D J Hilton (Australia) T Hirano (Japan) J Hiscott (Canada) J Keski-Oja (Finland) M Klagsbrun (USA) M Krönke (Germany) W Leonard (USA) D LeRoith (USA) D Levy (USA) K Miyazono (Japan) C F Nathan (USA)
J J Oppenheim (USA) R W Padgett (USA) S Pestka (USA) K Pfizenmaier (Germany) H A Reddi (USA) A B Roberts (USA) G Rodan (USA) J Schlessinger (USA) M D Schneider (USA) M B Sporn (UK) T Taniguchi (Japan) G Trinchieri (France) J Van Damme (Belgium) J T Vilcˇek (USA) S Wahl (USA) D Wallach (Israel) C Ware (USA)
Author enquiries: For enquiries relating to the submission of articles (including electronic submission where available) please visit Elsevier’s Author Gateway at http://authors.elsevier.com. The Author Gateway also provides the facility to track accepted articles and set up e-mail alerts to inform you of when an article’s status has changed, as well as detailed artwork guidelines, copyright information, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided after registration of an article for publication. Publication information: Cytokine and Growth Factor Reviews (ISSN 1359-6101). For 2006, volume 17 is scheduled for publication. Subscription prices are available upon request from the Publisher or from the Regional Sales Office nearest you or from this journal’s website (http://www.elsevier.com/locate/cytogfr). Further information is available on this journal and other Elsevier products through Elsevier’s website: (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch. Advertising information: Advertising orders and enquiries can be sent to: USA, Canada and South America: Mr Tino DeCarlo, The Advertising Department, Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710, USA; phone: (+1) (212) 633 3815; fax: (+1) (212) 633 3820; e-mail: [email protected]. Europe and ROW: Daniel Banks, Commercial Sales Department, Elsevier Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 3BL, UK; phone: (+44) (0) 1865 843652; fax: (+44) (0) 1865 843976; e-mail: [email protected] Orders, claims, and journal enquiries: please contact the Customer Service Department at the Regional Sales Office nearest you: Orlando: Elsevier, Customer Service Department, 6277 Sea Harbor Drive, Orlando, FL 32887-4800, USA; phone: (+1) (877) 8397126 [toll free number for US customers], or (+1) (407) 3454020 [customers outside US]; fax: (+1) (407) 3631354; e-mail: [email protected] Amsterdam: Elsevier, Customer Service Department, PO Box 211, 1000 AE Amsterdam, The Netherlands; phone: (+31) (20) 4853757; fax: (+31) (20) 4853432; e-mail: [email protected] Tokyo: Elsevier, Customer Service Department, 4F Higashi-Azabu, 1-Chome Bldg, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan; phone: (+81) (3) 5561 5037; fax: (+81) (3) 5561 5047; e-mail: [email protected] Singapore: Elsevier, Customer Service Department, 3 Killiney Road, #08-01 Winsland House I, Singapore 239519; phone: (+65) 63490222; fax: (+65) 67331510; e-mail: [email protected] USA mailing notice: Cytokine and Growth Factor Reviews (ISSN 1359-6101) is published bimonthly in February, April, June, August, October and December by Elsevier (P.O. Box 211, 1000 AE Amsterdam, The Netherlands). Annual subscription price in the USA US$ 704 (valid in North, Central and South America), including air speed delivery. Periodical postage rate is paid at Jamaica, NY 11431. USA POSTMASTER: Send address changes to Cytokine and Growth Factor Reviews, Publications Expediting Inc., 200 Meacham Ave, Elmont, NY 11003. AIRFREIGHT AND MAILING in the USA by Publications Expediting Inc., 200 Meacham Avenue, Elmont, NY 11003. © 2006 Elsevier Ltd. All rights reserved.
Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
CONTENTS Volume 16, Number 1 Surveys Transcriptional signaling by double-stranded RNA: role of TLR3 (G.C. Sen and S.N. Sarkar)
1
Dual role for TGF-1 in apoptosis (A. Sánchez-Capelo)
15
Tumor necrosis factor, cancer and anticancer therapy (S. Mocellin, C.R. Rossi, P. Pilati and D. Nitti)
35
Tumor therapeutics by design: targeting and activation of death receptors (H. Wajant, J. Gerspach and K. Pfizenmaier)
55
Transcriptional regulation of vascular endothelial growth factor in cancer (R.M.B. Loureiro and P.A. D’Amore)
77
Viral chemokine-modulatory proteins: tools and targets (J.M. Boomker, L.F.M.H. de Leij, T. Hauw The and M.C. Harmsen)
91
Facts and Faces Conference Calendar Information to Contributors
I V VII
Volume 16, Number 2 Special Issue: Fibroblast Growth Factors Editorial: Introduction to the special FGF issue (C. Basilico)
105
Structural basis for fibroblast growth factor receptor activation (M. Mohammadi, S.K. Olsen and O.A. Ibrahimi)
107
Cellular signaling by fibroblast growth factor receptors (V.P. Eswarakumar, I. Lax and J. Schlessinger)
139
FGF signaling in flies and worms: More and more relevant to vertebrate biology (P. Huang and M.J. Stern)
151
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis (M. Presta, P. Dell’Era, S. Mitola, E. Moroni, R. Ronca and M. Rusnati)
159
Fibroblast growth factor signaling in tumorigenesis (R. Grose and C. Dickson)
179
Bad bones, absent smell, selfish testes: The pleiotropic consequences of human FGF receptor mutations (A.O.M. Wilkie)
187
FGF signaling in the developing endochondral skeleton (D.M. Ornitz)
205
Volume Contents/Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
IX
Fibroblast growth factor homologous factors: Evolution, structure, and function (M. Goldfarb)
215
FGF23 and disorders of phosphate homeostasis (X. Yu and K.E. White)
221
Mechanisms underlying differential responses to FGF signaling (L. Dailey, D. Ambrosetti, A. Mansukhani and C. Basilico)
233
Facts and Faces Conference Calendar Information to Contributors
I III V
Volume 16, Number 3 Special Issue: Bone Morphogenetic Proteins Editorial BMPs: From bone morphogenetic proteins to body morphogenetic proteins (A.H. Reddi)
249
Reviews BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk (K. Miyazono, S. Maeda and T. Imamura)
251
BMP signaling and early embryonic patterning (S. Kishigami and Y. Mishina)
265
The role of bone morphogenetic proteins in endochondral bone formation (N. Tsumaki and H. Yoshikawa)
279
Bone Morphogenetic Protein signaling in joint homeostasis and disease (R.J.U. Lories and F.P. Luyten)
287
Bone morphogenetic proteins in development and homeostasis of kidney (P. Simic and S. Vukicevic)
299
BMP antagonists: Their roles in development and involvement in pathophysiology (M. Yanagita)
309
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation (R.L. van Bezooijen, P. ten Dijke, S.E. Papapoulos and C.W.G.M. Löwik)
319
Delivery of bone morphogenetic proteins for orthopedic tissue regeneration (H. Seeherman and J.M. Wozney)
329
Application of bone morphogenetic proteins in spinal fusion (M.C. Gupta and S.N. Khan)
347
Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: Experimental studies in the non-human primate Papio ursinus (U. Ripamonti, N.-N. Herbst and L.N. Ramoshebi)
357
Bone morphogenetic proteins in dentin regeneration for potential use in endodontic therapy (M. Nakashima)
369
Facts and Faces Conference Calendar Information to Contributors
I V VII
X
Volume Contents/Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
Volume 16, Numbers 4–5 Mini-reviews Should activin C be more than a fading snapshot in the activin/TGF family album? (C.M. Butler, E.J. Gold and G.P. Risbridger)
377
MicroRNAs: Small regulators with a big impact (M. Yang, Y. Li and R.W. Padgett)
387
Surveys Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension (J.L. Walker, A.K. Fournier and R.K. Assoian)
395
The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models (S. Yakar, D. LeRoith and P. Brodt)
407
Molecular interactions of the IGF system (A. Denley, L.J. Cosgrove, G.W. Booker, J.C. Wallace and B.E. Forbes)
421
RET tyrosine kinase signaling in development and cancer (E. Arighi, M.G. Borrello and H. Sariola)
441
Cytokines and junction restructuring during spermatogenesis—a lesson to learn from the testis (W. Xia, D.D. Mruk, W.M. Lee and C.Y. Cheng)
469
Smads and chromatin modulation (L.A. van Grunsven, G. Verstappen, D. Huylebroeck and K. Verschueren)
495
Cell biology of IL-7, a key lymphotrophin (Q. Jiang, W.Q. Li, F.B. Aiello, R. Mazzucchelli, B. Asefa, A.R. Khaled and S.K. Durum)
513
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis (M. Klagsbrun and A. Eichmann)
535
Facts and Faces Conference Calendar Information to Contributors
I V VII
Volume 16, Number 6 Special Issue: Chemokines Editorial From cytokines to chemokines (J. Van Damme and A. Mantovani)
549
Reviews Chemokines provide the sustained inflammatory bridge between innate and acquired immunity (A.L. Coelho, C.M. Hogaboam and S.L. Kunkel)
553
Synergy in cytokine and chemokine networks amplifies the inflammatory response (M. Gouwy, S. Struyf, P. Proost and J. Van Damme)
561
Dendritic cell trafficking: More than just chemokines (S. Sozzani)
581
Volume Contents/Cytokine & Growth Factor Reviews 17 (2006) VIII–XI
XI
CXC chemokines in angiogenesis (R.M. Strieter, M.D. Burdick, B.N. Gomperts, J.A. Belperio and M.P. Keane)
593
Dimerization of chemokine receptors and its functional consequences (J.-Y. Springael, E. Urizar and M. Parmentier)
611
Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention (Z. Johnson, A.E. Proudfoot and T.M. Handel)
625
Chemokine receptor internalization and intracellular trafficking (N.F. Neel, E. Schutyser, J. Sai, G.-H. Fan and A. Richmond)
637
HIV chemokine receptor inhibitors as novel anti-HIV drugs (K. Princen and D. Schols)
659
Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines (M. Locati, Y.M. de la Torre, E. Galliera, R. Bonecchi, H. Bodduluri, G. Vago, A. Vecchi and A. Mantovani)
679
Contribution of Duffy antigen to chemokine function (A. Rot)
687
Facts and Faces Conference Calendar Information to Contributors
I III IV
Cytokine & Growth Factor Reviews 17 (2006) XII–XIII
KEY WORD INDEX Achondroplasia 205 Activin C 377 Adaptive immunity 553 Adaptors 469 Adherens junction 469 Adhesion molecules 581 ADHR 221 Akt 15 Angiogenesis 77, 159, 535, 593 Angiostasis 593 Antagonist 659 Anti-angiogenesis 77 Antibody fusion protein 55 Antineoplastic agent 35 Antitumor therapy 35 Antiviral drugs 91 Apoptosis 15, 377, 513 Biopharmaceutics 91 Blood-testis barrier 469 BMP 251, 265 BMP-7 acute and chronic renal failure 299 Bone 187 Bone formation, BMP antagonist 319 Bone induction 357 Bone morphogenetic proteins (BMPs) 287, 329, 347, 357, 369, 495 C. elegans 151 Cadherin 395 Cancer 179, 407 Cartilage 279 CCR5 659 Cdk 513 Cell cycle 513 Cellular signaling 139 Chemokine receptor 637, 659, 679 Chemokine therapeutics 625 Chemokines 553, 561, 581, 593, 611, 625, 679, 687, 91 Chemotaxis 561 Composites 329 Cooperativity 611 Craniosynostosis 187, 205 CXCR4 659
Cyclin 395 Cystine-knot 309 Cytokines 469, 561 D6 679 DARC 687 Decoy receptors 679 Delivery systems 329 Dendritic cells 581 Dental pulp 369 Dental pulp capping 369 Development 387 Dimeric protein 377 Dimerization 139, 611 Double-stranded RNA 1 Drosophila 151 Ectodin 309 Ectoplasmic specialization 469 Embryogenesis 265 Embryonic patterning 265 Endocytosis 637 Endothelium 159, 687 Ephrin/Eph 535 ERK 469 Erythrocytes 687 FasL 15, 55 FGF 159, 205, 221, 233 FGF receptors 159, 179 FGF signaling 151 FGF23 221 FGFR 187, 233 FGFR stimulation 139 FGFs 179 Fibroproliferation 593 Fibrous dysplasia 221 Function 421 G1 phase 395 GAG 625 Gastrulation 265 GDNF 441 Gene regulation 387 Gene therapy 55, 329, 369 Gene transcription 233
Genetics 187 Glycosaminoglycan 625 GPCR 611 Growth factors 77, 377 Heparan sulfate proteoglycan 625 Heparin 625 Hirschsprung’s disease 441 Histones 495 HIV 659 IGF receptors 421 IGFBP 421 IL-7 513 Immune evasion 91 Immunosuppression 91 Induction 561 Inflammation 593, 679 Inhibin 377 Innate immunity 553 Inorganic carriers 329 Insulin-like growth factor 407, 421 Integrin 395 Interceptor 687 Internalization 637 JNK 15, 469 Junction restructuring 469 Kidney 299 Knockout mice 279 Leukocyte emigration 687 Mechanical force 395 Mesoderm 151 Metabolic bone disease 221 MicroRNA 387 Migration 151, 581 Modifications 637 Mouse models 407 Multiple endocrine neoplasia type 2 441 Natural polymers 329 Netrin/UNC5B 535
Keywords Index/Cytokine & Growth Factor Reviews 17 (2006) XII–XIII
Neuronal guidance 535 NF-B 15 Odontoblasts 369 Osteoarthritis 287 Osteocyte 319 Osteogenic protein-1 357 p38 15 p38 MAPK 469 Phosphate wasting 221 PI3 kinase 1 Primates 357 Receptor 265, 407 Receptor tyrosine kinase 205, 395 Receptor tyrosine phosphorylation 1 Receptors 581 Redundancy 357 Regeneration 369 Remodeling 495 Renal osteodystrophy 299 Reparative dentin 369 RET 441 rhBMP-2 347 rhBMP-7 347 Rheumatoid arthritis 287 rhGDF-5 347 RNA 387 ROS 15
Sclerosteosis/Van Buchem disease 319 Sclerostin 309 Semaphorin/neuropilin 535 Sepsis 553 Serine/threonine kinase receptor 251 Signal transduction 233, 495 Signaling cross-talk 251 Skeletal development 205 Slit/Robo 535 Smad 251, 495 Smads 279 Smurfs 279 SOST/sclerostin 319 Sperm 187 Spermatogenesis 469 Spinal fusion 347 Spondyloarthritis 287 Structure 421 Synergy 561 Synovial joint 287 Synthetic polymers 329 T cell 513 Testis 469 TGF- 251, 265 TGF- superfamily members 357 TGF-1 15 TGF-3 469
Thymus 513 Thyroid cancer 441 Tight junction 469 TIO 221 TNF 55 TNF 469 Toll-like receptor 3 1 Toll-like receptor (TLR) 553 Trafficking 637 TRAIL 55 Transcytosis 687 Transgenic mice 279 Tumor 159 Tumor necrosis factor (TNF) 35 Tumor targeting 55 Tumorgenesis 593 Tumors 535, 77 USAG-1 309 Vascular calcification 299 Vascularization 77 VEGF 77 Viral stress-inducible genes 1 Wise 309 Wnt signaling 233 XIAP 15 XLH 221
XIII
Cytokine & Growth Factor Reviews 17 (2006) XIV–XV
AUTHOR INDEX Aiello, F.B. 513 Ambrosetti, D. 233 Arighi, E. 441 Asefa, B. 513 Assoian, R.K. 395 Basilico, C. 105, 233 Belperio, J.A. 593 Bodduluri, H. 679 Bonecchi, R. 679 Booker, G.W. 421 Boomker, J.M. 91 Borrello, M.G. 441 Brodt, P. 407 Burdick, M.D. 593 Butler, C.M. 377 Cheng, C.Y. 469 Coelho, A.L. 553 Cosgrove, L.J. 421 Dailey, L. 233 Damme, J.V. 549 D’Amore, P.A. 77 de la Torre, Y.M. 679 de Leij, L.F.M.H. 91 Dell’Era, P. 159 Denley, A. 421 Dickson, C. 179 Durum, S.K. 513 Eichmann, A. 535 Eswarakumar, V.P. 139 Fan, G.-H. 637 Forbes, B.E. 421 Fournier, A.K. 395 Galliera, E. 679 Gerspach, J. 55 Gold, E.J. 377 Goldfarb, M. 215 Gomperts, B.N. 593 Gouwy, M. 561
Grose, R. 179 Gupta, M.C. 347 Handel, T.M. 625 Harmsen, M.C. 91 Herbst, N.-N. 357 Hogaboam, C.M. 553 Huang, P. 151 Huylebroeck, D. 495 Ibrahimi, O.A. 107 Imamura, T. 251 Jiang, Q. 513 Johnson, Z. 625 Keane, M.P. 593 Khaled, A.R. 513 Khan, S.N. 347 Kishigami, S. 265 Klagsbrun, M. 535 Kunkel, S.L. 553 Lax, I. 139 Lee, W.M. 469 LeRoith, D. 407 Li, W.Q. 513 Li, Y. 387 Locati, M. 679 Lories, R.J.U. 287 Loureiro, R.M.B. 77 Löwik, C.W.G.M. 319 Luyten, F.P. 287 Maeda, S. 251 Mansukhani, A. 233 Mantovani, A. 549, 679 Mazzucchelli, R. 513 Mishina, Y. 265 Mitola, S. 159 Miyazono, K. 251 Mocellin, S. 35 Mohammadi, M. 107 Moroni, E. 159
Mruk, D.D. 469 Nakashima, M. 369 Neel, N.F. 637 Nitti, D. 35 Olsen, S.K. 107 Ornitz, D.M. 205 Padgett, R.W. 387 Papapoulos, S.E. 319 Parmentier, M. 611 Pfizenmaier, K. 55 Pilati, P. 35 Presta, M. 159 Princen, K. 659 Proost, P. 561 Proudfoot, A.E. 625 Ramoshebi, L.N. 357 Reddi, A.H. 249 Richmond, A. 637 Ripamonti, U. 357 Risbridger, G.P. 377 Ronca, R. 159 Rossi, C.R. 35 Rot, A. 687 Rusnati, M. 159 Sai, J. 637 Sánchez-Capelo, A. 15 Sariola, H. 441 Sarkar, S.N. 1 Schlessinger, J. 139 Schols, D. 659 Schutyser, E. 637 Seeherman, H. 329 Sen, G.C. 1 Simic, P. 299 Sozzani, S. 581 Springael, J.-Y. 611 Stern, M.J. 151 Strieter, R.M. 593 Struyf, S. 561
Keywords Index/Cytokine & Growth Factor Reviews 17 (2006) XIV–XV
ten Dijke, P. 319 The, T.H. 91 Tsumaki, N. 279
Vecchi, A. 679 Verschueren, K. 495 Verstappen, G. 495 Vukicevic, S. 299
Wilkie, A.O.M. 187 Wozney, J.M. 329 Xia, W. 469
Urizar, E. 611 Vago, G. 679 van Bezooijen, R.L. 319 Van Damme, J. 561 van Grunsven, L.A. 495
Wajant, H. 55 Walker, J.L. 395 Wallace, J.C. 421 White, K.E. 221
Yakar, S. 407 Yanagita, M. 309 Yang, M. 387 Yoshikawa, H. 279 Yu, X. 221
XV